Research Paper Volume 15, Issue 15 pp 7811—7830
A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
Figure 9. Analysis of TMB, MSI, and immune checkpoints. (A) MSI analysis in different groups. (B) TMB analysis in different groups. (C) Expression of immune checkpoints among high- and low-risk groups. P values were showed as. Abbreviation: ns: not significant. *P < 0.05; **P < 0.01; ***P < 0.001.